DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $18.00 Average PT from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given an average recommendation of “Hold” by the fourteen brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $18.00.

Several research firms have issued reports on XRAY. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Finally, Barrington Research cut their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after acquiring an additional 557,329 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in DENTSPLY SIRONA by 11.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after acquiring an additional 1,412,517 shares during the last quarter. AQR Capital Management LLC grew its holdings in DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after acquiring an additional 6,970,086 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 4.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after acquiring an additional 538,531 shares during the last quarter. Finally, Lazard Asset Management LLC grew its holdings in DENTSPLY SIRONA by 8.0% during the 2nd quarter. Lazard Asset Management LLC now owns 10,107,657 shares of the medical instruments supplier’s stock worth $160,508,000 after acquiring an additional 745,421 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $12.51 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company has a fifty day simple moving average of $13.38 and a 200 day simple moving average of $14.51. The company has a market cap of $2.50 billion, a P/E ratio of -2.64, a P/E/G ratio of 0.78 and a beta of 0.96. DENTSPLY SIRONA has a 1 year low of $11.69 and a 1 year high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were given a dividend of $0.16 per share. The ex-dividend date was Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. DENTSPLY SIRONA’s dividend payout ratio is -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.